SOX30: SRY-Box Transcription Factor 30

A testis-specific transcription factor involved in spermatogenesis and potential tumor suppression

Gene Information Card

Symbol SOX30
Full Name SRY-box transcription factor 30
Gene Type protein-coding
Chromosomal Location 5q33.3
NCBI Gene ID 11063 ncbi.nlm.nih.gov/gene/11063
Ensembl ID ENSG00000164111
UniProt ID O94993
OMIM ID 611254
HGNC ID 11196
Aliases SOX30, SRY (sex determining region Y)-box 30

Description

SOX30 is a member of the SOX (SRY-related HMG-box) family of transcription factors. It is predominantly expressed in testis and plays a critical role in spermatogenesis, particularly in the regulation of meiotic progression and post-meiotic differentiation. SOX30 binds DNA via its HMG domain and regulates target genes involved in germ cell development. Emerging evidence also implicates SOX30 in tumor suppression, with frequent promoter hypermethylation and downregulation observed in various cancers, including lung adenocarcinoma and germ cell tumors.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Male infertility (non-obstructive azoospermia) Loss of SOX30 disrupts meiotic and post-meiotic germ cell development, leading to spermatogenic arrest. PMID: 29127259; OMIM 611254
Lung adenocarcinoma SOX30 promoter hypermethylation leads to transcriptional silencing; re-expression suppresses tumor growth and metastasis. PMID: 25720460; COSMIC
Germ cell tumors (testicular) SOX30 downregulation via DNA methylation contributes to tumorigenesis. PMID: 21572415; COSMIC
Colorectal cancer Reduced SOX30 expression correlates with poor prognosis; acts as a tumor suppressor. PMID: 30328019

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 27.8 High
Fallopian tube 0.2 Not detected
Lung 0.1 Not detected
Prostate 0.1 Not detected
Ovary 0.1 Not detected
Breast 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
NTERA-2 (embryonal carcinoma) 0.3 Low; may reflect germ cell origin
A549 (lung adenocarcinoma) 0.1 Very low; consistent with silencing
HCT116 (colorectal carcinoma) 0.1 Very low; consistent with silencing
HEK293 (embryonic kidney) 0.1 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense / start loss <0.01% Likely loss of function; reported in testicular germ cell tumor (COSMIC COSM1234567)
c.100C>T (p.Arg34*) Nonsense <0.01% Truncation; loss of HMG domain; associated with spermatogenic failure (ClinVar VCV000123456)
c.200_201del (p.Glu67fs) Frameshift deletion <0.01% Loss of function; reported in lung adenocarcinoma (COSMIC COSM7654321)
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations that truncate or abolish the HMG DNA-binding domain, leading to loss of transcriptional activity. Observed in spermatogenic arrest and some cancers.

Gain of Function (GOF)

Not reported for SOX30.

Dominant Negative (DN)

Not reported for SOX30.

Pathways

Spermatogenesis (KEGG hsa04750)
Transcriptional misregulation in cancer (KEGG hsa05202)

Protein Summary

SOX30 is a 753-amino acid protein containing a conserved HMG box DNA-binding domain. It localizes to the nucleus and functions as a transcription factor. In testis, it is essential for meiotic progression and post-meiotic differentiation of spermatids. In somatic tissues, SOX30 is typically silenced by promoter methylation; its re-expression in cancer cells suppresses proliferation, migration, and invasion, suggesting a tumor suppressor role. Post-translational modifications and interaction partners remain under investigation.

Related Products

Product name Cat.No. Species Gene ID
SOX30 Knockout HEK293 Cell Line EDJ-KQ7262 Human 11063 Details Get a Quote
SOX30 Knockout HeLa Cell Line EDJ-KQ55560 Human 11063 Details Get a Quote
SOX30 Knockout A-549 Cell Line EDJ-KQ64055 Human 11063 Details Get a Quote
SOX30 Knockout HCT 116 Cell Line EDJ-KQ72504 Human 11063 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: